Methyl N-[(1R)-2-[(2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-3-methyl-2-(propanoylamino)butanoyl]pyrrolidin-2-yl]-1H-indol-5-yl]thieno[3,2-b]thiophen-2-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
C49H51N7O5S2 — CID 123908764
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl N-[(1R)-2-[(2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-3-methyl-2-(propanoylamino)butanoyl]pyrrolidin-2-yl]-1H-indol-5-yl]thieno[3,2-b]thiophen-2-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
Methyl N-[(1R)-2-[(2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-3-methyl-2-(propanoylamino)butanoyl]pyrrolidin-2-yl]-1H-indol-5-yl]thieno[3,2-b]thiophen-2-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (PubChem CID 123908764) has the molecular formula C49H51N7O5S2 and a molecular weight of 882.13 g/mol. Its IUPAC name is methyl N-[(1R)-2-[(2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-3-methyl-2-(propanoylamino)butanoyl]pyrrolidin-2-yl]-1H-indol-5-yl]thieno[3,2-b]thiophen-2-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate.
Molecular Properties
| Compound Name | Methyl N-[(1R)-2-[(2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-3-methyl-2-(propanoylamino)butanoyl]pyrrolidin-2-yl]-1H-indol-5-yl]thieno[3,2-b]thiophen-2-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate |
|---|---|
| PubChem CID | 123908764 |
| Molecular Formula | C49H51N7O5S2 |
| Molecular Weight | 882.13 g/mol |
| Exact Mass | 881.34 |
| IUPAC Name | methyl N-[(1R)-2-[(2S)-2-[5-[4-[5-[2-[(2S)-1-[(2S)-3-methyl-2-(propanoylamino)butanoyl]pyrrolidin-2-yl]-1H-indol-5-yl]thieno[3,2-b]thiophen-2-yl]phenyl]-1H-imidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate |
| SMILES | CCC(=O)N[C@H](C(=O)N1CCC[C@H]1c1cc2cc(-c3cc4sc(-c5ccc(-c6cnc([C@@H]7CCCN7C(=O)[C@H](NC(=O)OC)c7ccccc7)[nH]6)cc5)cc4s3)ccc2[nH]1)C(C)C |
| InChI | InChI=1S/C49H51N7O5S2/c1-5-43(57)53-44(28(2)3)47(58)55-21-9-13-37(55)35-24-33-23-32(19-20-34(33)51-35)40-26-42-41(63-40)25-39(62-42)30-17-15-29(16-18-30)36-27-50-46(52-36)38-14-10-22-56(38)48(59)45(54-49(60)61-4)31-11-7-6-8-12-31/h6-8,11-12,15-20,23-28,37-38,44-45,51H,5,9-10,13-14,21-22H2,1-4H3,(H,50,52)(H,53,57)(H,54,60)/t37-,38-,44-,45+/m0/s1 |
| InChIKey | SKJWJDOLUUPRLQ-FYEHWKERSA-N |
| XLogP | 10.14 |
| TPSA | 152.52 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 63 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 882.13 |
| LogP ≤ 5 | 10.14 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123908764 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.